Kaplan buys Nuvectis Pharma (NVCT) shares worth $64,240
PositiveFinancial Markets
Kaplan buys Nuvectis Pharma (NVCT) shares worth $64,240
Kaplan has made a significant investment by purchasing shares of Nuvectis Pharma worth $64,240. This move highlights Kaplan's confidence in Nuvectis's potential for growth in the pharmaceutical sector, which could lead to exciting developments in healthcare and innovation.
— via World Pulse Now AI Editorial System





